Hypothyroidism
SpecialtyEndocrinology Edit this on Wikidata

Hypothyroidism is the disease state in humans and in vertebrates caused by insufficient production of thyroid hormones by the thyroid gland. Cretinism is a form of hypothyroidism found in infants.

Signs and symptoms

In adults, hypothyroidism is associated with the following symptoms:[1][2][3]

Early

Late

Uncommon

Causes

About three percent of the general population is hypothyroidic.[13] Factors such as iodine deficiency or exposure to Iodine-131 (I-131) can increase that risk. There are a number of causes for hypothyroidism. Iodine deficiency is the most common cause of hypothyroidism worldwide.[citation needed] In iodine-replete individuals hypothyroidism is generally caused by Hashimoto's thyroiditis, or otherwise as a result of either an absent thyroid gland or a deficiency in stimulating hormones from the hypothalamus or pituitary.

Hypothyroidism can result from postpartum thyroiditis, a condition that affects about 5% of all women within a year of giving birth.[citation needed] The first phase is typically hyperthyroidism; the thyroid then either returns to normal, or a woman develops hypothyroidism. Of those women who experience hypothyroidism associated with postpartum thyroiditis, one in five will develop permanent hypothyroidism requiring life-long treatment.

Hypothyroidism can also result from sporadic inheritance, sometimes autosomal recessive.[citation needed]

Hypothyroidism is also a relatively common disease in domestic dogs, with some specific breeds having a definite predisposition.[14]

Temporary hypothyroidism can be due to the Wolff-Chaikoff effect. A very high intake of iodine can be used to temporarily treat hyperthyroidism, especially in an emergency situation. Although iodine is substrate for thyroid hormones, high levels prompt the thyroid gland to take in less of the iodine that is eaten, reducing hormone production.

Hypothyroidism is often classified by the organ of origin[clarification needed]:[15][16]

Type Origin Description
Primary thyroid gland The most common forms include Hashimoto's thyroiditis (an autoimmune disease) and radioiodine therapy for hyperthyroidism.
Secondary pituitary gland Occurs if the pituitary gland does not create enough thyroid-stimulating hormone (TSH) to induce the thyroid gland to produce enough thyroxine and triiodothyronine. Although not every case of secondary hypothyroidism has a clear-cut cause, it is usually caused by damage to the pituitary gland, as by a tumor, radiation, or surgery.[1]
Tertiary hypothalamus Results when the hypothalamus fails to produce sufficient thyrotropin-releasing hormone (TRH). TRH prompts the pituitary gland to produce thyroid-stimulating hormone (TSH). Hence may also be termed hypothalamic-pituitary-axis hypothyroidism.

General psychological associations

Hypothyroidism can be caused by lithium-based mood stabilizers, usually used to treat bipolar disorder (previously known as manic depression).[citation needed]

In addition, patients with hypothyroidism and psychiatric symptoms may be diagnosed with:[17]

Diagnosis

To diagnose primary hypothyroidism, many doctors simply measure the amount of thyroid-stimulating hormone (TSH) being produced by the pituitary gland. High levels of TSH indicate that the thyroid is not producing sufficient levels of thyroid hormone (mainly as thyroxine (T4) and smaller amounts of triiodothyronine (T3)). However, measuring just TSH fails to diagnose secondary and tertiary hypothyroidism, thus leading to the following suggested blood testing if the TSH is normal and hypothyroidism is still suspected:

Additionally, the following measurements may be needed:

Treatment

Main article: Medical use of thyroid hormones

Hypothyroidism is treated with the levorotatory forms of thyroxine (L-T4) and triiodothyronine (L-T3). Both synthetic and animal-derived thyroid tablets are available and can be prescribed for patients in need of additional thyroid hormone. Thyroid hormone is taken daily, and doctors can monitor blood levels to help assure proper dosing. There are several different treatment protocols in thyroid replacement therapy:

T4 Only
This treatment involves supplementation of levothyroxine alone, in a synthetic form. It is currently the standard treatment in mainstream medicine.[19]
T4 and T3 in Combination
This treatment protocol involves administering both synthetic L-T4 and L-T3 simultaneously in combination.[20]
Desiccated Thyroid Extract
Desiccated thyroid extract is an animal based thyroid extract, most commonly from a porcine source. It is also a combination therapy, containing natural forms of L-T4 and L-T3.[21]

Treatment controversy

A 2000 paper suggested "clear improvements in both cognition and mood" from combination therapy,[20] [22] and another in 2001 concluded that combined treatment seemed to be more effective than treatment with T4 alone on eight main symptoms of hypothyroidism.[21]

However, more recent studies have shown no improvement in mood or mental abilities for those on combination therapy, and possibly impaired well-being from subclinical hyperthyroidism.[23] Another 2006 study which looked at the correlation between free T3 and free T4 levels and psychological well being in a randomized controlled trial of combined treatment found a strong correlation for free T4, but none for T3.[24]. A 2007 metaanalysis of the nine controlled studies so far published found no significant difference in the effect on psychiatric symptoms.[25].

In addition, a metaanlysis of 11 randomized controlled trials which looked at a wider range of symptoms including: bodily pain, anxiety, fatigue, body weight and a range of other factors, found no difference between the combined treatment and therapy with T4 alone.[26]

There is also concern among some practitioners about the use of T3 due to its short half-life. T3 when used on its own as a treatment results in wide fluctuations across the course of a day in the thyroid hormone levels, and with combined T3/T4 therapy there continues to be wide variation throughout each day.[27]

Subclinical hypothyroidism

Subclinical hypothyroidism occurs when thyrotropin (TSH) levels are elevated but thyroxine (T4) and triiodothyronine (T3) levels are normal.[13] Prevalence estimates range 3–8%, increasing with age; incidence is more common in women than in men.[28] In primary hypothyroidism, TSH levels are high and T4 and T3 levels are low. Endocrinologists are puzzled because TSH usually increases when T4 and T3 levels drop. TSH prompts the thyroid gland to make more hormone. Endocrinologists are unsure how subclinical hypothyroidism affects cellular metabolic rates (and ultimately the body's organs) because the levels of the active hormones are adequate. Some have proposed treating subclinical hypothyroidism with levothyroxine, the typical treatment for overt hypothyroidism, but the benefits and the risks are unclear. Reference ranges have been debated as well. The American Association of Clinical Endocrinologists (ACEE) considers 0.45–4.5 mIU/L, with the ranges down to 0.1 and up to 10 mIU/L requiring monitoring but not necessarily treatment.[29] There is always the risk of overtreatment and hyperthyroidism. Some studies have suggested that subclinical hypothyroidism does not need to be treated. A meta-analysis by the Cochrane Collaboration found no benefit of thyroid hormone replacement except "some parameters of lipid profiles and left ventricular function."[30] A more recent metanalysis looking into whether subclinical hypothyroidism may increase the risk of cardiovascular disease, as has been previously suggested,[31] found a possible modest increase and suggested further studies be undertaken with coronary heart disease as an end point "before current recommendations are updated."[32]

Alternative treatments

Alternative practitioners may combine conventional serum tests with less conventional tests to assess thyroid hormone function, or simply look at symptoms. Many have found that compounded slow release T3 used in combination with T4 may help to mitigate many of the symptoms of functional hypothyroidism and improve quality of life, although this is still controversial and is rejected by the conventional medical establishment.[33]

See also

References

  1. ^ a b American Thyroid Association (ATA) (2003). Hypothyroidism Booklet (PDF). p. 6.
  2. ^ MedlinePlus Encyclopedia: Hypothyroidism — primary — see list of Symptoms
  3. ^ "Hypothyroidism — In-Depth Report." The New York Times. Copyright 2008
  4. ^ "Hypothyroidism" (PDF). American Association of Clinical Endocrinologists.
  5. ^ Yeum CH, Kim SW, Kim NH, Choi KC, Lee J (2002). "Increased expression of aquaporin water channels in hypothyroid rat kidney". Pharmacol. Res. 46 (1): 85–8. doi:10.1016/S1043-6618(02)00036-1. PMID 12208125. ((cite journal)): Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  6. ^ Thyroid and Weight. The American Thyroid Association
  7. ^ Samuels MH (2008). "Cognitive function in untreated hypothyroidism and hyperthyroidism". Curr Opin Endocrinol Diabetes Obes. 15 (5): 429–33. doi:10.1097/MED.0b013e32830eb84c. PMID 18769215. ((cite journal)): Unknown parameter |doi_brokendate= ignored (|doi-broken-date= suggested) (help); Unknown parameter |month= ignored (help)
  8. ^ Neurologic manifestations of hypothyroidism Devon I Rubin, MD (Author), Michael J Aminoff, MD, Douglas S Ross, MD (Section Editors), Janet L Wilterdink, MD (Deputy Editor) – UpToDate.com, Last literature review version 17.3: September 2009; This topic last updated: March 18, 2009
  9. ^ Hofeldt FD, Dippe S, Forsham PH (1972). "Diagnosis and classification of reactive hypoglycemia based on hormonal changes in response to oral and intravenous glucose administration" (PDF). Am. J. Clin. Nutr. 25 (11): 1193–201. PMID 5086042.((cite journal)): CS1 maint: multiple names: authors list (link)
  10. ^ Jabbar A, Yawar A, Waseem S; et al. (2008). "Vitamin B12 deficiency common in primary hypothyroidism". J Pak Med Assoc. 58 (5): 258–61. PMID 18655403. ((cite journal)): Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  11. ^ Cracking the Metabolic Code (Volume 1 of 2) by James B. Lavalle R.Ph. C.C.N. N.D, ISBN 1442950390, page 100
  12. ^ Velázquez EM, Bellabarba Arata G (1997). "Effects of thyroid status on pituitary gonadotropin and testicular reserve in men". Arch. Androl. 38 (1): 85–92. doi:10.3109/01485019708988535. PMID 9017126.
  13. ^ a b Jack DeRuiter (2002). Thyroid Pathology (PDF). p. 30. Cite error: The named reference "Auburn University" was defined multiple times with different content (see the help page).
  14. ^ Brooks W (01/06/2008). "Hypothyroidism in Dogs". The Pet Health Library. VetinaryPartner.com. Retrieved 2008-02-28. ((cite web)): Check date values in: |date= (help)
  15. ^ Simon H (2006-04-19). "Hypothyroidism". University of Maryland Medical Center. Retrieved 2008-02-28.
  16. ^ Department of Pathology (June 13, 2005). "Pituitary Gland -- Diseases/Syndromes". Virginia Commonwealth University (VCU). Retrieved 2008-02-28.
  17. ^ Heinrich TW, Grahm G (2003). "Hypothyroidism Presenting as Psychosis: Myxedema Madness Revisited". Primary care companion to the Journal of clinical psychiatry. 5 (6): 260–6. doi:10.4088/PCC.v05n0603. PMC 419396. PMID 15213796.
  18. ^ Baisier WV, Hertoghe J, Eeckhaut W (2000). "Thyroid insufficiency. Is TSH the only diagnostic tool?". J Nutr Environ Med. 10 (2): 105–13. doi:10.1080/13590840050043521. ((cite journal)): Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  19. ^ American Association of Clinical Endocrinologists (2002). "Medical Guidelines For Clinical Practice For The Evaluation And Treatment Of Hyperthyroidism And Hypothyroidism" (PDF). Endocrine Practice. 8 (6): 457–469. PMID 15260011. ((cite journal)): Unknown parameter |month= ignored (help)
  20. ^ a b Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ (1999). "Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism". N. Engl. J. Med. 340 (6): 424–9. doi:10.1056/NEJM199902113400603. PMID 9971866. ((cite journal)): Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  21. ^ a b Baisier, W.V.; Hertoghe, J.; Eeckhaut, W. (2001). "Thyroid Insufficiency. Is Thyroxine the Only Valuable Drug?". Journal of Nutritional and Environmental Medicine. 11 (3): 159–66. doi:10.1080/13590840120083376. ((cite journal)): Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)Abstract
  22. ^ Robertas Bunevicius, Arthur J. Prange Jr. (2000). "Mental improvement after replacement therapy with thyroxine plus triiodothyronine: relationship to cause of hypothyroidism". The International Journal of Neuropsychopharmacology. 3 (2): 167–174. doi:10.1017/S1461145700001826. PMID 11343593. ((cite journal)): Unknown parameter |month= ignored (help)
  23. ^ Siegmund W, Spieker K, Weike AI; et al. (2004). "Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism". Clin. Endocrinol. (Oxf). 60 (6): 750–7. doi:10.1111/j.1365-2265.2004.02050.x. PMID 15163340. ((cite journal)): Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  24. ^ Ponnusamy Saravanan, Theo J. Visser and Colin M. Dayan (2006). "Psychological Well-Being Correlates with Free Thyroxine But Not Free 3,5,3'-Triiodothyronine Levels in Patients on Thyroid Hormone Replacement". The Journal of Clinical Endocrinology and Metabolism. 91 (9): 3389–3393. doi:10.1210/jc.2006-0414.
  25. ^ Joffe RT, Brimacombe M, Levitt AJ, Stagnaro-Green A (2007). "Treatment of clinical hypothyroidism with thyroxine and triiodothyronine: a literature review and metaanalysis". Psychosomatics. 48 (5): 379–84. doi:10.1176/appi.psy.48.5.379. PMID 17878495.((cite journal)): CS1 maint: multiple names: authors list (link)
  26. ^ Simona Grozinsky-Glasberg, Abigail Fraser, Ethan Nahshoni, Abraham Weizman and Leonard Leibovici (2006). "Thyroxine-Triiodothyronine Combination Therapy Versus Thyroxine Monotherapy for Clinical Hypothyroidism: Meta-Analysis of Randomized Controlled Trials". The Journal of Clinical Endocrinology and Metabolism. 91 (7): 2592–2599. doi:10.1210/jc.2006-0448.((cite journal)): CS1 maint: multiple names: authors list (link)
  27. ^ Saravanan P, Siddique H, Simmons DJ, Greenwood R, Dayan CM (2007). "Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy". Exp. Clin. Endocrinol. Diabetes. 115 (4): 261–7. doi:10.1055/s-2007-973071. PMID 17479444. ((cite journal)): Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  28. ^ Fatourechi V (2009). "Subclinical hypothyroidism: an update for primary care physicians". Mayo Clinic Proceedings. 84 (1): 65–71. doi:10.4065/84.1.65. PMC 2664572. PMID 19121255.
  29. ^ "Subclinical Thyroid Disease". Guidelines & Position Statements. The American Association of Clinical Endocrinologists. July 11, 2007. Retrieved 2008-06-08.
  30. ^ Villar H, Saconato H, Valente O, Atallah A (2007). "Thyroid hormone replacement for subclinical hypothyroidism". Cochrane database of systematic reviews (Online) (3): CD003419. doi:10.1002/14651858.CD003419.pub2. PMID 17636722.((cite journal)): CS1 maint: multiple names: authors list (link)
  31. ^ Biondi B, Palmieri EA, Lombardi G, Fazio S (2002). "Effects of subclinical thyroid dysfunction on the heart". Ann. Intern. Med. 137 (11): 904–14. PMID 12458990. ((cite journal)): Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  32. ^ Ochs N, Auer R, Bauer DC; et al. (2008). "Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality". Ann. Intern. Med. 148 (11): 832–45. PMID 18490668. ((cite journal)): Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  33. ^ Todd CH (2009). "Management of thyroid disorders in primary care: challenges and controversies". Journal of Postgraduate Medicine. 85 (1010): 655–9. PMID 20075403. ((cite journal)): Unknown parameter |month= ignored (help)

Further reading

This template is no longer used; please see Template:Endocrine pathology for a suitable replacement